Hyaluronic acid 20mg/mL, lidocaine 3mg/mL; injectable gel implant. Should only be used by trained and experienced healthcare practitioners. Obtain patient's complete medical history prior to ...

Galderma (SIX: GALD), the pure-play dermatology category leader, has announced the launch of Restylane Defyne and Restylane Refyne: the first OBT‑based hyaluronic acid injectables ever authorized in ...

There's a new filler in town (actually, two new fillers) and they're billed as the next big thing in the fight against laugh lines. Galderma, the pharmaceutical company behind injectables like ...

Millions of Americans have had their lips plumped and wrinkles smoothed with injectable fillers. But many complain facial expressions don't always look natural. Now two new entries in the filler ...

Add Yahoo as a preferred source to see more of our stories on Google. In the great big world of facial fillers, two of the most popular—Restylanë and Juvéderm—often get conflated. Patients often ask, ...

Please provide your email address to receive an email when new articles are posted on . Galderma announced it has received FDA approval of two new Restylane products for the treatment of nasolabial ...

Restylane Refyne and Restylane Defyne are the first Optimal Balance Technology (OBT) hyaluronic acid injectables ever approved and launched in Japan, bringing advanced flexibility and natural movement ...

This expands Galderma’s Restylane portfolio in Japan to four products, enabling treatment of a wider spectrum of patient and practitioner needs 3,4 These two new launches underscore Galderma’s ...